Abbott ABT Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Diagnostic Products | $9.06B+1.4% | $8.94B-0.7% | $9B-1.7% | $9.16B-0.2% | $9.18B-1.7% | |
| Established Pharmaceuticals | $5.7B+3.0% | $5.54B+2.1% | $5.42B+2.0% | $5.32B+1.7% | $5.23B+0.7% | |
| Medical Devices | $22.03B+3.0% | $21.39B+3.0% | $20.76B+3.5% | $20.06B+3.3% | $19.43B+2.3% | |
| Nutritional Products | $8.32B-1.5% | $8.45B-2.2% | $8.64B+1.0% | $8.55B+0.7% | $8.49B+0.9% | |
| Net Sales by Geography | ||||||
| International | $27.9B+2.6% | $27.2B+1.7% | $26.76B+2.4% | $26.12B+1.6% | $25.7B+0.3% | |
| United States | $17.23B+0.6% | $17.13B+0.2% | $17.08B+0.6% | $16.99B+2.1% | $16.65B+2.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Abbott break its business down?
- Abbott (ABT) reports net sales by business across 4 parts — Diagnostic Products, Established Pharmaceuticals, Medical Devices and Nutritional Products. Each is extracted from the segment footnotes and tracked over time.
- Where does Abbott's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Abbott's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
